Cost-Effectiveness of Lithium Versus an Atypical Anti-Psychotic (AAP) used to Augment Treatment with a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1264
https://www.valueinhealthjournal.com/article/S1098-3015(14)03194-5/fulltext
Title :
Cost-Effectiveness of Lithium Versus an Atypical Anti-Psychotic (AAP) used to Augment Treatment with a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03194-5&doi=10.1016/j.jval.2014.08.1264
First page :
A459
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
755